Skip to main content

Peer Review reports

From: Melatonin enhances everolimus efficacy in breast cancer by suppressing mTOR pathway activation and promoting apoptosis and mitochondrial function

Original Submission
2 Dec 2024 Submitted Original manuscript
10 Dec 2024 Author responded Author comments - CENK ARAL
Resubmission - Version 2
10 Dec 2024 Submitted Manuscript version 2
11 Dec 2024 Author responded Author comments - CENK ARAL
Resubmission - Version 3
11 Dec 2024 Submitted Manuscript version 3
20 Dec 2024 Author responded Author comments - CENK ARAL
Resubmission - Version 4
20 Dec 2024 Submitted Manuscript version 4
25 Jan 2025 Reviewed Reviewer Report
27 Jan 2025 Reviewed Reviewer Report - Qingfeng Yu
12 Feb 2025 Reviewed Reviewer Report
7 Mar 2025 Author responded Author comments - CENK ARAL
Resubmission - Version 5
7 Mar 2025 Submitted Manuscript version 5
10 Mar 2025 Author responded Author comments - CENK ARAL
Resubmission - Version 6
10 Mar 2025 Submitted Manuscript version 6
11 Mar 2025 Author responded Author comments - CENK ARAL
Resubmission - Version 7
11 Mar 2025 Submitted Manuscript version 7
13 Mar 2025 Author responded Author comments - CENK ARAL
Resubmission - Version 8
13 Mar 2025 Submitted Manuscript version 8
Publishing
17 Mar 2025 Editorially accepted
12 May 2025 Article published 10.1186/s40360-025-00907-1

You can find further information about peer review here.

Back to article page